Literature DB >> 10394481

Schizophrenia and the influenza epidemics of 1957 in Japan.

Y Izumoto1, S Inoue, N Yasuda.   

Abstract

BACKGROUND: We tested the hypothesis that the exposure to an influenza epidemic during the second trimester of gestation is associated with an increased risk of later development of schizophrenia.
METHODS: There were three influenza epidemics (A/B mixed type, the first A2 type and the second A2 type) in 1957 in Kochi, Japan. We compared the risk of developing schizophrenia in birth cohorts exposed to these three influenza epidemics during gestation with that in birth cohorts not exposed. To identify subjects who had developed schizophrenia, we surveyed patients with schizophrenia who received medical care at all psychiatric institutions in Kochi prefecture.
RESULTS: There is a pattern that schizophrenic births increase twice or more among female subjects who were exposed to each of three influenza epidemics in the fifth month of gestation. The increase in the female births exposed to the second A2 epidemic was significant (relative risk 2.86, 95% confidence interval 1.37-5.26). This pattern across the three epidemics was not observed in male subjects.
CONCLUSIONS: Prenatal exposure to an influenza epidemic during the second trimester increased the risk of later development of schizophrenia in female births.

Entities:  

Mesh:

Year:  1999        PMID: 10394481     DOI: 10.1016/s0006-3223(98)00359-x

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  16 in total

Review 1.  The role of obstetric events in schizophrenia.

Authors:  Mary Catherine Clarke; Michelle Harley; Mary Cannon
Journal:  Schizophr Bull       Date:  2005-11-23       Impact factor: 9.306

2.  Association between prenatal exposure to bacterial infection and risk of schizophrenia.

Authors:  Holger J Sørensen; Erik L Mortensen; June M Reinisch; Sarnoff A Mednick
Journal:  Schizophr Bull       Date:  2008-10-01       Impact factor: 9.306

Review 3.  What risk factors tell us about the causes of schizophrenia and related psychoses.

Authors:  J Kelly; R M Murray
Journal:  Curr Psychiatry Rep       Date:  2000-10       Impact factor: 5.285

Review 4.  Modeling the molecular epigenetic profile of psychosis in prenatally stressed mice.

Authors:  Alessandro Guidotti; Erbo Dong; Patricia Tueting; Dennis R Grayson
Journal:  Prog Mol Biol Transl Sci       Date:  2014       Impact factor: 3.622

Review 5.  The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.

Authors:  Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2003-02-25       Impact factor: 4.530

Review 6.  Prenatal infection and schizophrenia: a review of epidemiologic and translational studies.

Authors:  Alan S Brown; Elena J Derkits
Journal:  Am J Psychiatry       Date:  2010-02-01       Impact factor: 18.112

7.  Schizophrenia and 1957 pandemic of influenza: meta-analysis.

Authors:  Jean-Paul Selten; Aleida Frissen; Gerty Lensvelt-Mulders; Vera A Morgan
Journal:  Schizophr Bull       Date:  2009-12-03       Impact factor: 9.306

8.  Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions.

Authors:  Richard S Ehrlichman; Steven N Luminais; Samantha L White; Noam D Rudnick; Nan Ma; Holly C Dow; Arati S Kreibich; Ted Abel; Edward S Brodkin; Chang-Gyu Hahn; Steven J Siegel
Journal:  Brain Res       Date:  2009-07-28       Impact factor: 3.252

Review 9.  Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications.

Authors:  Vijay A Mittal; Lauren M Ellman; Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2008-07-17       Impact factor: 9.306

10.  Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice.

Authors:  Francesco Matrisciano; Patricia Tueting; Ishani Dalal; Bashkim Kadriu; Dennis R Grayson; John M Davis; Ferdinando Nicoletti; Alessandro Guidotti
Journal:  Neuropharmacology       Date:  2012-04-28       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.